Skip to main content

Table 2 Biochemical parameters and findings

From: Multidisciplinary assessment of tako tsubo cardiomyopathy: a prospective case study

Variable Initial findings 48 hours 3 months P
Troponin I (mg/L) 2.70 (0.45-2.90) 0.42 (0.17-0.76) Not measured < 0.001
Creatine kinase μkat/L 2.55 (1.58-3.15) 1.50 (1.00-1.90) Not measured 0.03
Creatin kinase MB (μg/L) 11.60 (5.35-22.33) 4.40 (2.80-5.10) Not measured 0.002
NT pro-brain natriuretic peptide (ng/L) 389 (228-447) 313 (275-702) Not measured 0.32
High-sensitivity C-reactive protein (mg/L) 4.10 (2.90-6.70) 10.50 (7.10-19.60) Not measured 0.02
Thyroid-stimulating hormone (mIU/L) 1.20 (0.68-1.70) Not measured 1.10 (0.90-1.50) 0.97
Thyroxine (pmol/L) 14.30 (13.60-15.50) Not measured 14.00 (13.30-15.00) 0.57
Cholesterol (mmol/L) 6.10 (5.30-6.60) Not measured 5.40 (4.40-6.00) 0.57
Low-density lipoprotein cholesterol (mmol/L) 3.60 (2.70-4.40) Not measured 3.00 (2.10-3.50) 0.52
High-density lipoprotein cholesterol (mmol/L) 1.50 (1.20-1.50) Not measured 1.40 (1.30-1.60) 0.18
Triglyceride (mmol/L) 1.60 (1.20-2.20) Not measured 1.50 (1.20-2.40) 0.41
Plasma adrenalin (nmol/l) * 0.30 (0.30-0.40) Not measured 0.30 (0.30-0.30) 1.00
Plasma noradrenalin (nmol/l) * 3.70 (2.60-5.50) Not measured 3.30 (2.50-3.40) 0.06
  1. Values are median (interquartile range) or number (percentage).
  2. *Complete data from 7 patients only